ArticleJournal of pain research2024
Erratum: Efficacy and Safety of Rimegepant 75 Mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial [Corrigendum].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.